Description

Selepressin (CAS No. 876296-47-8) is a synthetic peptide and selective vasopressin V1A receptor agonist with potent vasopressor activity. It has demonstrated the ability to modulate vascular permeability and maintain endothelial integrity in preclinical research models. Manufactured under GMP standards with a purity of 99.34%, Selepressin ensures consistent and reliable performance for experimental studies. This product is intended strictly for laboratory research use and is not approved for clinical or therapeutic applications.

Product Specifications

Mechanism of Action & Research Applications

Selepressin functions as a selective vasopressin V1A receptor agonist. Its research applications include:

• Vasopressor Activity: Enhances vascular tone and increases mean arterial pressure in preclinical models.

• Vascular Barrier Modulation: Reduces vascular leakage and preserves endothelial integrity.

• Septic Shock Research: Models hemodynamic regulation and vascular responses in experimental septic shock.

• Endothelial Studies: Investigates mechanisms of endothelial cell function and barrier protection.

• Hemodynamic Research: Supports studies of blood pressure regulation and organ perfusion.

These activities make Selepressin a versatile tool for research in vascular biology, hemodynamics, and septic shock models.

Side Effects (For Reference Only in Models)

In preclinical studies, Selepressin has been generally well tolerated. Observed effects may include transient changes in blood pressure or vascular responses. No clinical or human-use data is included; research is strictly limited to laboratory studies.

Disclaimer

Selepressin is intended strictly for laboratory research use only. It is not approved for clinical or therapeutic applications. Follow institutional safety protocols during handling.